Table 3.

Prioritisation categories of patients planned for SACT

Level	Treatment
1	Curative treatment with a high (more than 50%) chance of success. Adjuvant or neoadjuvant treatment which adds at least 50% chance of cure to surgery or radiotherapy alone or treatment given at relapse
2	Curative treatment with an intermediate (20 to 50%) chance of success. Adjuvant or neoadjuvant treatment which adds 20 to 50% chance of cure to surgery or radiotherapy alone or treatment given at relapse
3	Curative treatment with a low (10 to 20%) chance of success Adjuvant or neoadjuvant treatment which adds 10 to 20% chance of cure to surgery or radiotherapy alone or treatment given at relapse Non-curative treatment with a high (more than 50%) chance of more than 1-year extension to life
4	Curative treatment with a very low (0 to 10%) chance of success. Adjuvant or neoadjuvant treatment which adds less than 10% chance of cure to surgery or radiotherapy alone or treatment given at relapse Non-curative treatment with an intermediate (15 to 50%) chance of more than 1-year extension to life
5	Non-curative treatment with a high (more than 50%) chance of palliation or temporary tumour control and less than 1-year expected extension to life
6	Non-curative treatment with an intermediate (15 to 50%) chance of palliation or temporary tumour control and less than 1-year expected extension to life